SOX11 is a biomarker for cyclin D1-negative mantle cell lymphoma. 2016

Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY 10595 USA.

Cyclin D1 (CCND1) protein overexpression and/or the t(11;14)(q13;q32) translocation are the pathognomonic hallmarks of mantle cell lymphoma (MCL). However, there have been cases that lacked both t(11;14) and cyclin D1 protein but still had a gene expression profile suggesting a diagnosis of MCL. SOX11 expression was detected in most cyclin D1- negative MCL and can serve as a specific biomarker for the diagnosis of this subset of MCL. Lack of SOX11 expression in MCL was associated with an indolent subset and favorable prognosis.

UI MeSH Term Description Entries

Related Publications

Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
February 2012, The American journal of surgical pathology,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
November 2009, Haematologica,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
February 2013, Blood,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
December 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
February 2024, Annals of hematology,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
October 2012, Histopathology,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
June 2017, Current oncology reports,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
September 2017, Blood,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
March 2013, Blood,
Roshni Narurkar, and Mohammad Alkayem, and Delong Liu
April 2022, International journal of surgical pathology,
Copied contents to your clipboard!